XRT-01. LONG-TERM HEARING LOSS IN CHILDREN WITH MEDULLOBLASTOMA AFTER PROTON IRRADIATION AND CHEMOTHERAPY

PURPOSE: To evaluate the incidence and risk factors for hearing loss (HL) among children with medulloblastoma treated with proton irradiation and cisplatin. METHODS: We identified children with medulloblastoma ≥3 years of age treated at Texas Children’s Hospital between 2007-2022. Audiograms were gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Arja, Mohammad H, Brown, Austin L, Su, Jack M, Okcu, M Fatih, Lindsay, Holly B, McGovern, Susan L, McAleer, Mary Frances, Grosshans, David R, Chintagumpala, Murali M, Paulino, Arnold C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Radiation Oncology - XRT
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259931/
http://dx.doi.org/10.1093/neuonc/noad073.297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259931/
http://dx.doi.org/10.1093/neuonc/noad073.297

Ejemplares similares